Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia

Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthase, has been proposed to be a mediator of vascular dysfunction during hyperhomocysteinemia. Levels of ADMA are regulated by dimethylarginine dimethylaminohydrolase (DDAH). Using both in vitro and in vivo approache...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Dayal, Sanjana, Rodionov, Roman N., Arning, Erland, Bottiglieri, Teodoro, Kimoto, Masumi, Murry, Daryl J., Cooke, John P., Faraci, Frank M., Lentz, Steven R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Physiological Society 2008
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2519228/
https://ncbi.nlm.nih.gov/pubmed/18567702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.01348.2007
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi